FindTrial
Sign In

Measurement of indoor air pollution exposure and health impact analysis in patients with idiopathic pulmonary fibrosis

Measurement of indoor air pollution exposure and health impact analysis in patients with idiopathic pulmonary fibrosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006217
Enrollment
260
Registered
2021-06-02
Start date
2022-10-06
Completion date
Unknown
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Meet the international diagnostic guidelines for IPF in the ATS/ERS/JRS/ALAT revised in 2018 -Forced vital capacity 40%-80% pred and diffusing capacity for carbon monoxide 30-80% pred are satisfied in the lung function test.

Exclusion criteria

Exclusion criteria: -Under 50 -Smoker

Design outcomes

Primary

MeasureTime frame
disease progression including death, hospitalization, and decline in forced vital capacity—

Secondary

MeasureTime frame
changes in lung function measured by home spirometry, changed in biomarker—

Countries

Korea, Republic of

Contacts

Public ContactHee Young Yoon

Soon Chun Hyang University Hospital Seoul

bluecat-s@hanmail.net+82-2-2036-0404

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 7, 2026